Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
<p>Figure S2. Lurbinectedin sensitivity (IC50) correlation with MYC expression and changes in expression of NE markers.</p>
Salvato in:
| Autore principale: | Subhamoy Chakraborty (16648124) (author) |
|---|---|
| Altri autori: | Charles Coleman (16648127) (author), Parvathy Manoj (16648130) (author), Deniz Demircioglu (15306139) (author), Nisargbhai Shah (16648133) (author), Elisa de Stanchina (14954757) (author), Charles M. Rudin (11572933) (author), Dan Hasson (15306151) (author), Triparna Sen (14126577) (author) |
| Pubblicazione: |
2025
|
| Soggetti: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Documenti analoghi
Documenti analoghi
-
Figure S1 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
di: Subhamoy Chakraborty (16648124)
Pubblicazione: (2025) -
Figure S3 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
di: Subhamoy Chakraborty (16648124)
Pubblicazione: (2025) -
Supplementary Tables 1-3 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
di: Subhamoy Chakraborty (16648124)
Pubblicazione: (2025) -
Filamin A KO and S2152A KI reduce KSHV de novo infection of cell-free virions.
di: Xiaojuan Li (351842)
Pubblicazione: (2025) -
Filamin A KO and S2152A KI reduce KSHV de novo infection and cell-contact mediated viral infection.
di: Xiaojuan Li (351842)
Pubblicazione: (2025)